Immediate Management of Lithium Level 2.2 mEq/L
Stop lithium immediately—a level of 2.2 mEq/L represents severe toxicity requiring urgent intervention with aggressive hydration, close monitoring, and strong consideration for hemodialysis. 1
Severity Assessment
A lithium level of 2.2 mEq/L is significantly toxic. The FDA label clearly states that patients may exhibit toxic signs at levels of 1.0-1.5 mEq/L, and therapeutic levels for acute mania should only range between 1.0-1.5 mEq/L 1. Your patient's level exceeds even the upper therapeutic range by nearly 50%, placing them at high risk for severe neurotoxicity, cardiac complications, and renal injury.
Immediate Actions
1. Discontinue Lithium
- Stop all lithium doses immediately
- Do not resume until levels normalize and clinical toxicity resolves
2. Assess Clinical Toxicity
Look specifically for:
- Neurological: Coarse tremor, confusion, ataxia, dysarthria, seizures, altered consciousness
- Gastrointestinal: Severe nausea, vomiting, diarrhea
- Cardiac: Bradycardia, T-wave changes, AV block (lithium can cause these arrhythmias) 2
- Renal: Polyuria from nephrogenic diabetes insipidus, oliguria if acute kidney injury develops
3. Initiate Aggressive Hydration
- Start IV normal saline to enhance renal lithium clearance
- Monitor fluid balance carefully—avoid overhydration in patients with cardiac or renal compromise
- Conservative management with electrolyte solutions and diuretics has been successful even at levels of 2.42 mmol/L 3, but your patient requires close monitoring
4. Consider Hemodialysis
Hemodialysis is the most effective method for rapidly removing lithium and should be strongly considered when:
- Lithium level >2.5 mEq/L
- Severe neurological symptoms (altered mental status, seizures)
- Renal failure or significantly impaired renal function
- Level >2.0 mEq/L with moderate-to-severe symptoms
At 2.2 mEq/L, the decision depends on clinical presentation. If the patient has significant neurological symptoms or renal impairment, proceed with dialysis. If relatively asymptomatic with normal renal function, aggressive hydration with very close monitoring may suffice 3.
Monitoring Requirements
- Serum lithium levels: Every 4-6 hours initially until declining trend established, then every 12-24 hours
- Renal function: Serum creatinine, BUN, electrolytes
- Cardiac monitoring: Continuous ECG if symptomatic; baseline ECG at minimum given cardiac risks 2
- Neurological status: Frequent assessments for progression of toxicity
Common Pitfalls
Do not rely solely on the lithium level—clinical toxicity assessment is equally important 1. Some patients develop severe symptoms at lower levels, while others tolerate higher levels better.
Check for precipitating factors:
- Dehydration (most common)
- NSAIDs, ACE inhibitors, thiazide diuretics (reduce lithium clearance) 4
- Acute illness causing volume depletion
- Recent dose increase or medication interactions
After Acute Management
Once the patient stabilizes and lithium levels normalize:
- Investigate the cause: Was this intentional overdose, medication error, drug interaction, or dehydration? 5
- Re-evaluate lithium appropriateness: Consider whether lithium remains the best option or if alternatives (valproate, carbamazepine, atypical antipsychotics) should be used 6
- If restarting lithium: Begin at lower dose (300 mg TID or QID), target maintenance levels of 0.6-1.2 mEq/L 1, and monitor levels twice weekly until stable
- Patient education: Provide written and verbal information about toxicity signs, importance of hydration, avoiding NSAIDs, and regular monitoring 5, 4
The margin between therapeutic and toxic lithium levels is narrow, and this episode represents a serious adverse event requiring thorough investigation and prevention strategies 5.